Francesca Ruzzi
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Immunotherapy and Immune Responses
Papers in
-
- Glycosylation and Glycoproteins Research 2
- FOXO transcription factor regulation 1
- Protein Degradation and Inhibitors 1
-
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 2
- Co-authors
- Pier‐Luigi Lollini (20 shared papers)Lorena Landuzzi (14 shared papers)Patrizia Nanni (9 shared papers)Arianna Palladini (12 shared papers)Katia Scotlandi (6 shared papers)Giordano Nicoletti (3 shared papers)Maria Cristina Manara (4 shared papers)Marianna L. Ianzano (3 shared papers)
- Journals
- Cancers (3 papers)Cancer Research (2 papers)International Journal of Molecular Sciences (2 papers)Journal of Cell Communication and Signaling (1 paper)Journal of Hematology & Oncology (1 paper)
- Partner nations
- ItalyUnited StatesDenmark
In The Last Decade
Francesca Ruzzi
19 papers receiving 254 citations
Peers
Comparison fields: 5 of 51
- Oncology 90
- Immunology 65
- Cancer Research 41
- Pulmonary and Respiratory Medicine 64
- Biotechnology 19
Countries citing papers authored by Francesca Ruzzi
This map shows the geographic impact of Francesca Ruzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Ruzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Ruzzi more than expected).
Fields of papers citing papers by Francesca Ruzzi
This network shows the impact of papers produced by Francesca Ruzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Ruzzi. The network helps show where Francesca Ruzzi may publish in the future.
Co-authors
The 25 scholars most cited alongside Francesca Ruzzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 53 | |
| 2 | 2023 | 34 | |
| 3 | 2024 | 21 | |
| 4 | 2022 | 21 | |
| 5 | 2024 | 21 | |
| 6 | 2021 | 20 | |
| 7 | 2021 | 20 | |
| 8 | 2021 | 17 | |
| 9 | 2019 | 10 | |
| 10 | 2024 | 8 | |
| 11 | 2023 | 7 | |
| 12 | 2022 | 6 | |
| 13 | 2022 | 4 | |
| 14 | 2025 | 4 | |
| 15 | 2025 | 4 | |
| 16 | 2024 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2021 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2023 | 0 |
About Francesca Ruzzi
Francesca Ruzzi is a scholar working on Molecular Biology, Immunology, Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 21 papers that have together received 255 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Sarcoma Diagnosis and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (2 papers), FOXO transcription factor regulation (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Oncology (90 citations), Immunology (65 citations), Cancer Research (41 citations), Pulmonary and Respiratory Medicine (64 citations) and Biotechnology (19 citations). Francesca Ruzzi has collaborated with scholars based in Italy, United States and Denmark. Frequent co-authors include Pier‐Luigi Lollini, Lorena Landuzzi, Patrizia Nanni, Arianna Palladini, Katia Scotlandi, Giordano Nicoletti, Maria Cristina Manara, Marianna L. Ianzano, Davide María Donati and Michela Pasello. Their work appears in journals such as Cancers, Cancer Research, International Journal of Molecular Sciences, Journal of Cell Communication and Signaling and Journal of Hematology & Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.